Published
A volunteer in Bhopal died days after participating in Covaxin's third phase trial. The Family members have raised questions over his suspicious death. Meanwhile, Bharat Biotech has issued a clarification. The reason being stated by them is suspected poisoning while they maintain that the death has nothing do with their vaccine shot or the placebo.Watch this News report to know more.
- Category
- Asia
- Tags
- Coronavirus, India, China
Sign in or sign up to post comments.
Be the first to comment
Up Next
Autoplay
-
01:34
Bharat Biotech seeks emergency use approval for Covaxin
-
15:01
Bharat Biotech की Covaxin का Trial Dose लेने वाले Anil Vij Corona Positive| Hindi News | Latest News
-
02:14
WHO grants emergency use license to Bharat Biotech's COVAXIN
-
02:02
Bharat Biotech advises people with medical conditions to avoid Covaxin
-
09:11
Covaxin Phase 1 Trial Clears Lancet Review, Phase 3 Trial Ongoing
-
03:21
Bharat Biotech's Covaxin consignment reaches Delhi
-
02:36
Bharat Biotech Applies For Permission For Phase I Trial Of Nasal Coronavirus Vaccine
-
05:46
AMU Vice-Chancellor Registers Himself As First Volunteer Of Covaxin Phase-3 Trial
-
02:24
Delhi Government vs Bharat Biotech Over Covaxin Supply
-
03:40
Covid-19 News: 70-80% Decline In Participants For Phase3 Trial Of Bharat Biotech's Covaxin
-
10:26
Covid-19 Vaccine: Bharat Biotech Releases Covaxin's Phase 3 Trial Data, Claims 77.8% Efficacy
-
03:21
Brazil Contradicts Bharat Biotech Claim On Emergency Approval For Covaxin
-
01:44
Covaxin safe, forms antibodies, claims Bharat Biotech
-
00:25
COVID-19 News: Bharat Biotech Seeks Emergency Use Approval For Covaxin
-
02:23
Bharat Biotech Enrols Over 25,000 Volunteers For Covaxin Phase 3 Trial
-
07:36
Covid-19 Vaccine: Covaxin Overall 77.8% Effective, Claims Bharat Biotech In Final Phase 3 Data
-
00:56
Covid-19 Vaccine: Bharat Biotech's Covaxin Approval Requested In US For Children Below 18
-
05:00
Expert Committee की ओर से दी गई Bharat Biotech की Covaxin को Emergency इस्तेमाल की मंजूरी
-
01:54
Covaxin के तीसरे Phase का ट्रायल होगा शुरू, Anil Vij होंगे Volunteer | World News
-
00:38
WHO Suspends UN Supply Of Covaxin; No Impact On Efficacy: Bharat Biotech
-
02:42
Covaxin Shows Interim Efficacy Of 81% In Phase 3 Results: Bharat Biotech
-
03:48
WHO Approves Bharat Biotech's Covaxin For Emergency Use
Loading...